Solinatra and Paques Biomaterials partner to commercialise PHBV for biodegradable single‑use plastics
Key highlights
- Solinatra Europe B.V. and Paques Biomaterials B.V. signed a Joint Development Plan and Conditional Offtake Agreement to commercialise PHBV biopolymers for biodegradable single‑use plastics.
- Paques will supply PHBV produced from residual organic waste streams for integration into Solinatra’s compounding portfolio.
- The programme runs from lab validation (targeted 2026) through semi‑industrial and industrial pilots, with commercial supply expected from 2028.
- Solinatra intends to source significant commercial volumes subject to successful development and certification.
Related project
For subscribers
Milestones, plant data, involved companies (owners, investors, licensors, contractors) and news — kept up to date.
Paques Biomaterials Emmen Caleyda PHA Extraction Plant · The Netherlands
FID / Sanctioned
2022
2024-01
—
—
~2026
Partnership
Solinatra Europe B.V. and Paques Biomaterials B.V. signed a Joint Development Plan and Conditional Offtake Agreement to jointly develop and commercialise PHBV biopolymers as biodegradable alternatives to fossil-based single-use plastics.
Technology and supply
Paques will supply PHBV produced from residual organic waste streams for formulation into Solinatra’s compounded material portfolio, supporting conversion by brand owners and converters away from conventional plastics.
Development and commercialisation timeline
The programme covers lab validation targeted for 2026, followed by semi-industrial and industrial pilots, with commercial supply expected from 2028; Solinatra intends to source significant commercial volumes subject to successful development and certification.
Source: Paques Biomaterials